FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sandoz Cetirizine HCl Chewable Tablet Recall

Cetirizine HCl Chewable Tablet, 10 mg, 6-tablets in one blister, in 12 (2 blisters) and…

Sandoz, Inc · Princeton, NJ

Risk level
Class III
Reported by FDA
Jun 10, 2015
Recall ID
D-1115-2015
Check your lot numberHow we source this data

Summary

Sandoz recalled Cetirizine HCl Chewable Tablet starting Apr 15, 2015. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1115-2015 on Jun 10, 2015. Reason: Failed Impurities/Degradation Specifications: An out of specification (OOS) result was reported for impurity at the 21 month stability time point. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: An out of specification (OOS) result was reported for impurity at the 21 month stability time point.

Product description

Cetirizine HCl Chewable Tablet, 10 mg, 6-tablets in one blister, in 12 (2 blisters) and 24 (4 blisters) tablet count configurations. Manufactured by Sandoz Private Limited Village-Digham Opp. Thane-Belapur Road Navi Mumbai, 400 078, India, for Sandoz Private Limited 100 College Road West, Princeton, NJ 08540. NDC 66394-041-06

Lot numbers, UPCs & expiration codes

Lot #: DP3841, DP5237, DP5238, DP5238A, DP5238B Exp 05/2015; DR7807, DR9954, DR9959, DV5838, Exp 07/2015.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1115-2015
Classification
Class III
Status
Terminated
Recall initiated
Apr 15, 2015
FDA report date
Jun 10, 2015
Quantity
1,023,430 units
Recall type
Voluntary: Firm initiated
Recalling firm
Sandoz, Inc

Original FDA data

Every field from FDA enforcement report D-1115-2015, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
71055
Address
506 Carnegie Ctr Ste 400
Code information
Lot #: DP3841, DP5237, DP5238, DP5238A, DP5238B Exp 05/2015; DR7807, DR9954, DR9959, DV5838, Exp 07/2015.
Postal code
08540-6243
Report date
Jun 10, 2015
Product type
Drugs
Recall number
D-1115-2015
Classification
Class III
Recalling firm
Sandoz, Inc
Product quantity
1,023,430 units
Termination date
Oct 5, 2016
Reason for recall
Failed Impurities/Degradation Specifications: An out of specification (OOS) result was reported for impurity at the 21 month stability time point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cetirizine HCl Chewable Tablet, 10 mg, 6-tablets in one blister, in 12 (2 blisters) and 24 (4 blisters) tablet count configurations. Manufactured by Sandoz Private Limited Village-Digham Opp. Thane-Belapur Road Navi Mumbai, 400 078, India, for Sandoz Private Limited 100 College Road West, Princeton, NJ 08540. NDC 66394-041-06
Distribution pattern
Nationwide
Recall initiation date
Apr 15, 2015
Initial firm notification
Letter
Center classification date
Jun 3, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1115-2015, published Jun 10, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls